NYSE:RFL - Post Discussion
Post by
AviseAnalytics on Nov 29, 2021 6:49am
5 REASONS WHY RAFAEL HOLDINGS IS A RISKY INVESTMENT!
$RFL
Rafael Holdings Inc, whose subsidiaries include Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd, has announced a realignment of the management team.
The move comes on the heels of the Company’s subsidiary Rafael Pharmaceuticals announcing that its lead candidate devimistat (CPI-613) failed to achieve its primary objective of overall survival (OS) in a crucial Phase III trial and another trial in acute myeloid leukemia (AML) was halted due to lack of efficacy.
We take a look at the Company's pipeline and its prospects in our article today.
https://www.aviseanalytics.com/5-reasons-why-rafael-holdings-is-a-risky-investment/
Be the first to comment on this post